Area of research
Physiology · Psychiatry and Mental health
Research interest
Research interests include Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research, Functional Brain Connectivity Studies, and Advanced Neuroimaging Techniques and Applications.
A cerebrospinal fluid synaptic protein biomarker for prediction of cognitive resilience versus decline in Alzheimer’s disease
Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease
Longer scans boost prediction and cut costs in brain-wide association studies
Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-β status, APOE genotype and sex
Synaptic loss pattern is constrained by brain connectome and modulated by phosphorylated tau in Alzheimer’s disease
Prediction of longitudinal synaptic loss in Alzheimer's disease using tau PET and plasma biomarkers
Connectivity as a universal predictor of tau progression in atypical Alzheimer’s disease
SV2A-PET imaging uncovers cortical synapse loss in multiple sclerosis
Microglial Activation and Tau Accumulation in the Alzheimer's Disease Spectrum: Insights from Longitudinal PET Imaging
Amyloid pathology and vascular risk are associated with distinct patterns of cerebral white matter hyperintensities: A multicenter study in 3132 memory clinic patients
Associations between sex, body mass index and the individual microglial response in Alzheimer’s disease
Magnetic Resonance Imaging Measures to Track Atrophy Progression in Progressive Supranuclear Palsy in Clinical Trials
Neuronal and oligodendroglial, but not astroglial, tau translates to in vivo tau PET signals in individuals with primary tauopathies
Neuroinflammation Parallels <scp>18F</scp> ‐ <scp>PI</scp> ‐2620 Positron Emission Tomography Patterns in Primary 4‐Repeat Tauopathies
Remote Neuroinflammation in Newly Diagnosed Glioblastoma Correlates with Unfavorable Clinical Outcome
Regional desynchronization of microglial activity is associated with cognitive decline in Alzheimer’s disease
Connectome-based modelling of neurodegenerative diseases: towards precision medicine and mechanistic insight
Individual regional associations between Aβ-, tau- and neurodegeneration (ATN) with microglial activation in patients with primary and secondary tauopathies
Association of Neurofilament Light Chain, [ <sup>18</sup> F]PI-2620 Tau-PET, TSPO-PET, and Clinical Progression in Patients With β-Amyloid–Negative CBS
Associations between sex, body mass index and the individual microglial response in Alzheimer’s disease
Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease
Tau deposition patterns are associated with functional connectivity in primary tauopathies
Strategic white matter hyperintensity locations for cognitive impairment: A multicenter lesion‐symptom mapping study in 3525 memory clinic patients
Microglial Activation and Connectivity in Alzheimer Disease and Aging
Additive value of [18F]PI-2620 perfusion imaging in progressive supranuclear palsy and corticobasal syndrome
Frequency and Longitudinal Course of Motor Signs in Genetic Frontotemporal Dementia
MRI connectivity-based spread of microglial activation in early Alzheimer's disease
Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases
KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer’s disease
Associations between sex, body mass index, and the individual microglial response in Alzheimer’s disease